What's new in guidance? BHIVA guidelines on the management of HIV in pregnancy and the postpartum period 2025

The Obstetrician & GynaecologistEarly View Update What's new in guidance? BHIVA guidelines on the management of HIV in pregnancy and the postpartum period 2025 Abha Govind FFSRH, FRCOG, Corresponding Author Abha Govind FFSRH, FRCOG [email protected] Consultant Obstetrician Gynaecologist, North Middlesex University Hospital NHS Trust, London, UKSearch for more papers by this author Abha Govind FFSRH, FRCOG, Corresponding Author Abha Govind FFSRH, FRCOG [email protected] Consultant Obstetrician Gynaecologist, North Middlesex University Hospital NHS Trust, London, UKSearch for more papers by this author First published: 23 September 2025 https://doi.org/10.1111/tog.70012Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookxLinkedInRedditWechatBluesky No abstract is available for this article. References 1 BHIVA-guidelines-on-the-management-of-HIV-in-pregnancy-and-the-postpartum-period.pdf. https://bhiva.org/wp-content/uploads/2025/06/ Google Scholar 2 University of Liverpool HIV drug interactions website. https://www.hiv-druginteractions.org Google Scholar 3 NHS Infectious Diseases in Pregnancy Screening (IDPS) programme. https://www.gov.uk/guidance/infectious-diseases-in-pregnancy-screening-programme-overview Google Scholar 4 NHS England. Infectious diseases in pregnancy screening programme: laboratory handbook. 2022 Accessed June 2024. https://www.gov.uk/government/publications/infectious-diseases-in-pregnancy-screeningprogramme-laboratory-handbook Google Scholar 5 NHS England. ISOSS HIV report 2022. 2023 Accessed March 2024. https://www.gov.uk/government/publications/infectious-diseases-in-pregnancy-screening-isoss-hivreport-2022/isoss-hiv-report-2022 Google Scholar 6 BHIVA/BASHH guidelines on the use of pre-exposure prophylaxis (PrEP) 2018. Accessed July 2024. https://www.bhiva.org/file/5b729cd592060/2018-PrEP-Guidelines.pdf Google Scholar 7 UK guideline for the use of HIV post-exposure prophylaxis 2021. Accessed June 2024. https://www.bhiva.org/file/6183b6aa93a4e/PEP-guidelines.pdf Google Scholar 8Foster C, Lees AE, Lyall EGH, et al. DDIPost-exposure prophylaxis (PEP) guidelines for infants, children and adolescents potentially exposed to blood-borne viruses. 2023 Accessed October 2024. https://www.chiva.org.uk/wp-content/uploads/2023/11/CHIVA_PEP_2023-Final.pdf Google Scholar 9Gross MS, Taylor HA, Tomori C, Coleman JS. Breastfeeding with HIV: an evidence-based case for new policy. J Law Med Ethics 2019; 47: 152–60. 10.1177/1073110519840495 PubMed Web of Science® Google Scholar 10Ramos MI, Sánchez BS, Orellana DM, Illán Ramos M, Soto Sánchez B, Mazariegos Orellana D, et al. Safety and experience with combined antiretroviral prophylaxis in newborn at high-risk of perinatal HIV infection, in a cohort of mother living with HIV-infant pairs. Pediatr Infect Dis J 2021; 40: 1096–100. 10.1097/INF.0000000000003297 PubMed Web of Science® Google Scholar 11Foster C, Lees EA, Lyall EGH, et al. Post-exposure prophylaxis (PEP) guidelines for infants, children and adolescents potentially exposed to blood-borne viruses. 2023 Accessed July 2024. https://www.chiva.org.uk/wp-content/uploads/2023/11/CHIVA_PEP_2023-Final.